Threshold US · Senior housing

Nursing home supply in Delaware

44 certified nursing homes · 4,717 certified beds · CMS Care Compare
44
certified nursing homes
4,717
certified beds
107
average beds per home
1,926
beds in 1 or 2-star homes (at-risk supply)

CMS rating mix

Certified beds by CMS overall 5-star rating across Delaware. Beds in 1 and 2-star homes are supply that may not survive, and therefore latent replacement demand.

5-star395 beds
4-star1,172 beds
3-star1,086 beds
2-star1,531 beds
1-star395 beds
Not rated138 beds

Largest markets by beds

CityHomesBeds
Wilmington141,565
Dover5480
Milford3380
Newark5364
Smyrna2326
Millsboro2311
Hockessin3286
Seaford3249

Ownership

Ownership typeHomesBeds
For Profit - Limited Liability Company202,569
For Profit - Corporation8926
Non Profit - Corporation8330
For Profit - Individual3324
Government - State2319

Largest nursing homes

HomeCityBedsCMS rating
Ocean Grove Post AcuteMillsboro1812-star
Excelcare At Lewes LlcLewes1792-star
Pike Creek Nursing & Rehabilitation CenterWilmington1772-star
Cadia Rehabilitation Pike CreekWilmington1774-star
Delaware Hospital F/T Chronically Ill (Dhci)Smyrna1752-star
Regal Heights Healthcare & Rehab CenterHockessin1722-star
Coral Springs Rehab & HealthcareWilmington1691-star
Evergreen Post AcuteSmyrna1513-star

The demand gap

Coming shortly: the population aged 85+ in each catchment and the demand gap against the national rate, from US Census Bureau data (being finalized). Supply above is live now from CMS. Join the waitlist to be first in when the Delaware demand analysis goes live.

Appraise any Delaware site in 60 seconds

Threshold US Care is launching in 2026. Drop a pin anywhere in Delaware: every competing certified bed and its CMS rating, the demand gap, and the maximum land bid. Reserve founding access for Delaware now.

Join the Delaware waitlist

All states → · The US senior care gap →

Supply: CMS Care Compare Provider Information (public domain), latest release. Every figure is a statistical estimate for site screening, not a USPAP appraisal or investment advice.